Tuesday, September 25, 2012

Presentations RULES


1.     You're presenting an ARTICLE: who wrote it? What is the author's point? What are the author's arguments? Do you agree or disagree? What is your analysis of the article? How would you open that topic to a further discussion?

2.     You must send me the article in WORD format. Your file should be presented as follows:
·      Title & Author. Ex: "Biotech Sector Seeks Funding" by Harrison Tucker
·      Source & Date: The Economist, Sept 21st, 2012
·      TEXT of the article
·      Link to the online version.
PLEASE follow these guidelines.

3.     In the TOPIC of your email, please write L1 PLUS, L2 PLUS, L2 PACES. For the regular TDs, please write "L1, Tuesday 1:30pm" if you're attending the Tuesday 1:30 pm class.

4.     You MUST send it to me BEFORE class, because if you chose an article that is inappropriate I won't be able to tell you before class and you will get an "out of topic" grade, which is never going to be over 8/20. 

The Hobbit boosts New Zealand film industry


Peter Jackson's two-part fantasy epic The Hobbit helped New Zealand's film industry contribute more than $2.4bn to the country's economy in 2011, according to a new report.
Figures released this week by Statistics New Zealand detail a 4% rise over 2010's headline figure. The Hobbit's importance to the Kiwi economy was highlighted in October 2010 when ministers promised to rewrite the country's labour laws and offer a $25m tax break to the Hollywood studio Warner Bros in order to ensure the Lord of the Rings prequel was shot on the same location as its predecessor.
Gisella Carr, chief executive of locations marketing agency FilmNZ, told the Hollywood Reporter the boost was not just about Jackson's adaptation of JRR Tolkien's childrens' novel. "[It's] everyone in the screen industry playing their part, whether they are working on international or domestic production, or both," she said. "We could never have imagined the scale of these figures a generation ago. It is a testament to our screen entrepreneurs who are converting creative projects into economic headlines."
Big-budget Hollywood films shot wholly or partly in New Zealand in recent years include Avatar, 10,000 BC, The Chronicles of Narnia: The Lion, the Witch and the Wardrobe and X-Men Origins: Wolverine. Thirty five productions visited the country in 2011, contributing revenue of more than $563m – up 15% year-on-year. "We are holding our own internationally, the level of revenue is increasing from year to year – despite a global recession and despite the fact that much of the screen industry runs on a project basis with breaks between activities," Carr added. "We are now starting to see trends over time, and what is emerging is a picture of consistent growth and sustainability."
The figures, while encouraging, are still dwarfed by those of the US film industry, which generated $40.8bn in 2011. The world's largest movie-maker is trailed by India, whose burgeoning industry is believed to contribute around $640m to the country's economy. The Chinese film industry was worth about 16 billion yuan ($2.5bn) in 2010. The UK film industry is worth about £4.2bn ($6.7bn) annually.
The Hobbit, which will be screened in two parts, the first arriving in December this year and the second in time for the following festive season, has had a chequered path to production, prompting a steady stream of tabloid stories suggesting a "Hobbit curse". Setbacks include the departure of original director Guillermo del Toro in 2010 after extended delays relating to studio MGM's financial travails, a fire that destroyed a number of vital miniatures, an enormous row with a local New Zealand union which prompted the labour law changes, and Jackson's own hospitalisation last year for surgery to treat a stomach ulcer.
The cast, including Martin Freeman, Andy Serkis, Benedict Cumberbatch, Cate Blanchett, Christopher Lee, Elijah Wood, Martin Freeman, Orlando Bloom, Sir Ian McKellen, Billy Connolly and Stephen Fry, is now complete and the shoot for The Hobbit: An Unexpected Journey began just over a year ago at Stone Street studios in Miramar, Wellington, and on location around New Zealand.

Fresh funding for biotech sector


High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our Ts&Cs and Copyright Policy for more detail. Email ftsales.support@ft.com to buy additional rights.http://www.ft.com/cms/s/0/359fc348-f8d5-11e0-a5f7-00144feab49a.html#ixzz27YPHW371


The fund, run by SL Investment Management, based in Chester, offers fresh hope to the British biotech sector, which has long complained of the lack of finance available in the UK compared with the US.
It aims to provide far earlier stage funding than most existing private equity groups, in the belief that it can build a diversified portfolio of investments sufficient to trigger significant returns.
Sir Richard, the former chairman of GlaxoSmithKline, head of Imperial College and now chairman of the Royal Institution, will head an independent board scrutinising the quality of the investments.
Ian Warwick, the managing partner, said that up to two-thirds of the projects would be based in the UK, with initial investments of $3m-$12m, later increasing to up to $20m-$30m, with the aim of exiting after five to seven years.
He said Deepbridge would identify projects patented by researchers in universities, take equity stakes of 80-90 per cent, incentivise the inventors and provide the management to develop the businesses.
“Our goal is to take products to the proof of relevance stage, not to full commercialisation but to get them to a significant level and pass them on to someone with deeper pockets,” he said.

Friday, September 21, 2012

CLASS @ 8:15 am next week !

Guys,

We're having class at 8:15 am NEXT WEEK.

Please let everyone know. I'm going to post this on EPREL as well.

Don't forget to get ready for your presentation !

Best

CJ